Capote, Zenith D.

HRN: 25-79-27  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/26/2024
CEFTRIAXONE 1G (VIAL)
08/26/2024
09/16/2024
IV
2G
OD
CKD SEC TO SLE
Waiting Final Action 
08/27/2024
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
08/27/2024
09/05/2024
ORAL
5cc
TID
Mouth Sores
Waiting Final Action 
08/28/2024
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
08/28/2024
09/21/2024
TIV
200mg
OD
Oral Candidiasis
Waiting Final Action 
08/30/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
08/30/2024
08/30/2024
INTRALUMEN
80mg
Now
IJC Prophylaxis
Waiting Final Action 
08/30/2024
MUPIROCIN 2%, 15G (TUBE)
08/30/2024
09/05/2024
TOPICAL
Apply Thin Coat
BID
IJC Prophylaxis
Waiting Final Action 
09/02/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
09/02/2024
09/02/2024
IVTT
80mg
Stat Dose
IJ Prophylaxis
Waiting Final Action 
09/04/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
09/04/2024
09/04/2024
INTRALUMEN
80mg
STAT
IJ Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: